Clinical Trials Directory

Trials / Terminated

TerminatedNCT01047774

The Effect of Soy Protein on Post- Breast Cancer Surgery Pain

Soy-rich Diet for Preventing Chronic Pain After Breast Cancer Surgery

Status
Terminated
Phase
Phase 2
Study type
Interventional
Enrollment
6 (actual)
Sponsor
Dr. Yoram Shir · Academic / Other
Sex
Female
Age
21 Years – 99 Years
Healthy volunteers
Not accepted

Summary

The incidence of chronic pain after breast cancer surgery (CPBCS) is high in women diagnosed with breast cancer. Similar to other chronic postoperative pain conditions, existing treatments for CPBCS do not always work. Adopting the concept of using pain relieving measures prior to surgery rather than after it, may lead to decreased postoperative pain levels. Soy has been shown to have pain-relieving properties and may reduce the risk for developing chronic post-surgical pain. The purpose of this study is to determine the effects of adding soy protein to the diet before surgery on the development of chronic pain.

Detailed description

Preclinical studies indicate that soy consumption suppresses the development of pain behavior and hyperalgesia following nerve injury. The pain-suppressing properties of soy protein have been shown to be predominately the result of soy pre-operative consumption. This is a randomized, double blind, placebo-controlled clinical trial for women diagnosed with breast cancer and scheduled to undergo breast cancer surgery. The trial will comprise two phases: 1. A 2-week preoperative dietary manipulation phase, and 2. A one-year postoperative follow up period. In the first phase eligible candidates will undergo a basic dietary evaluation followed by stratification into 4 study groups, based on their pre-vs. postmenopausal status and the planned type of surgery, i.e., formal mastectomy vs. breast-conserving surgery. Women in each group will be randomized to receive either powdered soy protein in the experimental group or milk protein in the control group. During the second, post-surgical phase women will resume their normal diet. If shown to be beneficial, this simple dietary manipulation may prevent one of the most severe sequelae of breast cancer.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTIsolated soy protein30-50g of protein powder daily for 2 weeks.
DIETARY_SUPPLEMENTIsolated milk protein30-50g of protein powder daily for 2 weeks.

Timeline

Start date
2010-03-01
Primary completion
2013-05-01
Completion
2013-05-01
First posted
2010-01-13
Last updated
2015-10-07

Locations

4 sites across 1 country: Canada

Source: ClinicalTrials.gov record NCT01047774. Inclusion in this directory is not an endorsement.